Pediatric hypertension /

Por Ingelfinger, Julie R.
Publicado em 1982

A Remembrance of Mary Ellen Avery, M.D.

Por Ingelfinger, Julie R.
Publicado em 2014

Estimated GFR and Risk of Death — Is Cystatin C Useful?

Por Ingelfinger, Julie R., Marsden, Philip A.
Publicado no N Engl J Med (2013)

Pediatric hypertension

Por Flynn, Joseph T., Ingelfinger, Julie R., Portman, Ronald J.
Publicado em 2011

Pediatric hypertension

Por Flynn, Joseph., Ingelfinger, Julie R., Portman, Ronald J.
Publicado em c201

Averting the legacy of kidney disease: focus on childhood

Por Ingelfinger, Julie R., Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no J Nephrol (2016)

In time: averting the legacy of kidney disease – focus on childhood

Por Ingelfinger, Julie R., Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no Rev Paul Pediatr (2016)

Averting the legacy of kidney disease – focus on childhood

Por Ingelfinger, Julie R., Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no Afr J Prim Health Care Fam Med (2016)

Averting the Legacy of Kidney Disease—Focus on Childhood

Por Ingelfinger, Julie R., Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no Am J Hypertens (2016)

Erratum to "In time: averting the legacy of kidney disease - focus on childhood" [Rev. Paul. Pediatr. 34 (1) (2016) 5-10]

Por Ingelfinger, Julie R, Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no Rev Paul Pediatr (2016)

Averting the Legacy of Kidney Disease—Focus on Childhood

Por Ingelfinger, Julie R., Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no Children (Basel) (2016)

Averting the Legacy of Kidney Disease - Focus on Childhood

Por Ingelfinger, Julie R., Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no Kidney Dis (Basel) (2016)

Erratum to: Averting the legacy of kidney disease: focus on childhood

Por Ingelfinger, Julie R., Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no J Nephrol (2016)

Averting the legacy of kidney disease: focus on childhood

Por Ingelfinger, Julie R, Kalantar-Zadeh, Kamyar, Schaefer, Franz
Publicado no Future Sci OA (2016)

Gellis & Kagan's Current pediatric therapy,15 /

Por Burg, Frederic D., Wald, Ellen R., Ingelfinger, Julie., Polin, Richard A.
Publicado em 1996

Normal Glomerular Permeability and Its Modification by Minimal Change Nephrotic Syndrome

Por Robson, Alan M., Giangiacomo, Joseph, Kienstra, Randy A., Naqvi, Saiyid T., Ingelfinger, Julie R.
Publicado em 1974

Panel Discussion: Early Nutrition in Adult Disease Prevention

Por Kwiterovich, Peter O., Ingelfinger, Julie, Leibel, Rudolph L., Lauer, Ronald M., Olson, Christine
Publicado em 1989

Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells

Por Satou, Ryousuke, Miyata, Kayoko, Gonzalez-Villalobos, Romer A., Ingelfinger, Julie R., Navar, L. Gabriel, Kobori, Hiroyuki
Publicado em 2012

Heterogeneous Nuclear Ribonucleoprotein F Suppresses Angiotensinogen Gene Expression and Attenuates Hypertension and Kidney Injury in Diabetic Mice

Por Lo, Chao-Sheng, Chang, Shiao-Ying, Chenier, Isabelle, Filep, Janos G., Ingelfinger, Julie R., Zhang, Shao Ling, Chan, John S.D.
Publicado em 2012

Catalase Prevents Maternal Diabetes–Induced Perinatal Programming via the Nrf2–HO-1 Defense System

Por Chang, Shiao-Ying, Chen, Yun-Wen, Zhao, Xin-Ping, Chenier, Isabelle, Tran, Stella, Sauvé, Alexandre, Ingelfinger, Julie R., Zhang, Shao-Ling
Publicado em 2012